Mesoblast
Quarterly Financials
| Values in thousands | 2023-12-31 |
|---|---|
Revenue | $1,694 |
Gross Profit | -8,002 |
EBITDA | -12,780 |
EBIT | -13,292 |
Net Income | -16,269 |
Net Change In Cash | 1,694 |
Free Cash Flow | -41 |
Cash | 77,144 |
Basic Shares | 851,464 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $5,902 | $7,501 | $10,211 | $7,456 |
Gross Profit | -9,815 | -20,232 | -20,546 | -25,263 |
EBITDA | -51,482 | -65,029 | -76,573 | -107,603 |
EBIT | -56,148 | -69,136 | -80,953 | -111,867 |
Net Income | -87,956 | -81,889 | -91,347 | -98,811 |
Net Change In Cash | 5,902 | 7,501 | 10,211 | 7,456 |
Free Cash Flow | -56,005 | -63,583 | -66,014 | -108,328 |
Cash | 62,960 | 70,920 | 60,034 | 136,881 |
Basic Shares | 851,464 | 77,945 | 129,766 | 119,080 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-03-31 | $0 |
2023-12-31 | $0 |
2023-09-30 | -$0.13 |
